Membrane-Bound Organelles

Nucleus

• Structure: double-membrane nuclear envelope with nuclear pores; contains chromatin (DNA + proteins) and the nucleolus.

• Function: houses the genome; coordinates DNA replication, transcription, and RNA processing; ribosome subunit assembly occurs in the nucleolus.

• Key concepts:

  • Nuclear envelope separates transcription in the nucleus from translation in the cytosol.

  • Nuclear pores regulate bidirectional traffic of molecules (e.g., mRNA out, transcription factors in).

  • Chromatin organization (euchromatin vs. heterochromatin) affects gene expression.

• Connections to other organelles:

  • mRNA transcripts are produced here and then exported to the cytosol for translation by ribosomes.

  • Proteins destined for the nucleus often contain nuclear localization signals (NLS) that direct them back through the nuclear pore complex.

• Relevance and implications:

  • Regulation of gene expression is centralized in the nucleus; mutations affecting nuclear transport can disrupt multiple cellular processes.

Endomembrane System Overview (context for membrane-bound organelles)

• The endomembrane system includes the nuclear envelope, endoplasmic reticulum (ER), Golgi apparatus, lysosomes, vesicles, endosomes, and the plasma membrane.

• Proteins are synthesized and processed within this system, then targeted to their final locations (secreted, membrane-bound, or lysosomal).

• Rough ER vs. Smooth ER recapped:

  • Rough ER: ribosome-studded; synthesizes secreted and membrane proteins; initial folding and quality control; early glycosylation.

  • Smooth ER: no ribosomes; lipid synthesis, detoxification, calcium storage.

Golgi Apparatus

• Structure: a series of flattened membrane-bound cisternae with cis (entry) and trans (exit) faces; cis-Golgi network (CGN) and trans-Golgi network (TGN).

• Functions:

  • Post-translational modification: further processing of N-linked and O-linked glycosylation, sulfation, phosphorylation of proteins.

  • Sorting and packaging: decides final destinations (secreted, lysosomal, or plasma membrane proteins).

  • Quality control: ensures properly folded and modified proteins proceed.

• Trafficking rules and players:

  • COPII vesicles move cargo from ER to Golgi; COPI vesicles mediate retrograde transport back toward ER; Clathrin-coated vesicles handle cargo to lysosomes, plasma membrane, or endosomes.

  • SNAREs and Rab GTPases guide vesicle targeting and fusion.

• Significance:

  • Central hub in the secretory pathway; defects can lead to mis-sorting and disease.

Vesicular Transport and Endomembrane Trafficking (key concepts)

• Vesicles bud from donor compartments, transport cargo, and fuse with target membranes.

• Essential components:

  • Coat proteins (COPII, COPI, Clathrin) for budding and cargo selection.

  • Tethering factors and SNAREs for docking and fusion.

  • Rab GTPases regulate vesicle identity and movement along cytoskeleton tracks.

• Pathways:

  • Anterograde (ER to Golgi to plasma membrane/lysosome).

  • Retrograde (Golgi back to ER) to retrieve escaped resident proteins and maintain compartment identity.

• Practical example:

  • A secreted protein is synthesized in the rough ER, trafficked to the Golgi for processing, sorted in the TGN, packaged into secretory vesicles, and released by exocytosis at the plasma membrane.

Mitochondria

• Structure: double-membrane envelope with inner membrane folded into cristae; matrix inside inner membrane; own circular DNA and ribosomes.

• Function: powerhouse of the cell; conducts the TCA cycle in the matrix and oxidative phosphorylation across the inner membrane to produce ATP; also involved in apoptosis regulation and metabolic signaling.

• Significance:

  • Energy production is central to most cellular activities; dysfunction linked to numerous diseases.

Lysosomes

• Structure: membrane-bound organelles with an acidic lumen (pH around pH \approx 4.5-5.0); contain a broad set of hydrolytic enzymes.

• Function: degrade macromolecules via acid hydrolases; involved in autophagy, endocytosis, and material recycling.

• Targeting and regulation:

  • Lysosomal enzymes are tagged with mannose-6-phosphate for proper trafficking from the Golgi to lysosomes.

• Significance:

  • Critical for turnover of cellular waste; lysosomal dysfunction underlies several storage diseases.

Peroxisomes

• Structure: single-membrane-enclosed organelles containing enzymes for redox reactions.

• Functions:

  • Beta-oxidation of very long-chain fatty acids;

  • Detoxification of reactive oxygen species (e.g., via catalase);

  • Involvement in metabolism of plasmalogens and bile acids.

• Targeting: proteins import via peroxisomal targeting signals (PTS1, PTS2).

Chloroplasts (in plants and algae)

• Structure: double membrane with internal thylakoid membranes organized into stacks (grana) and a fluid stroma.

• Function: site of photosynthesis; light reactions generate ATP and NADPH; Calvin cycle uses CO₂ to synthesize sugars.

• Significance:

  • Energy capture from light drives primary production in ecosystems; have their own DNA and ribosomes, reflecting endosymbiotic origin.

Vacuoles

• Plant cells: central vacuole large and membrane-bound; maintains turgor pressure, stores ions and nutrients, degrades waste.

• Animal cells: smaller vesicular vacuoles involved in storage and transport.

Plasma Membrane (cell boundary and signaling)

• Structure: phospholipid bilayer with embedded proteins; fluid mosaic model; glycoproteins and glycolipids involved in signaling.

• Functions:

  • Selective permeability and transport (channels, carriers, pumps);

  • Receptors for signaling molecules; anchors for cytoskeleton; defines cell shape and interaction with the environment.

• Relationship to endomembrane system:

  • proteins destined for the plasma membrane or secretion pass through the Golgi and are delivered via vesicles to the membrane.

Integrated Picture: Secretory Pathway — Step-by-Step (example)

• Step 1: Translation begins in cytosol; if the protein is destined for secretion or for the membrane, a signal peptide targets the ribosome to the rough ER.

• Step 2: Cotranslational translocation into the rough ER lumen or membrane insertion; folding and initial quality control by chaperones (e.g., BiP, calnexin) and formation of disulfide bonds.

• Step 3: Post-translational modifications in the ER (e.g., N-linked glycosylation) and initial sorting (retention vs. exit signals).

• Step 4: Transport from ER to Golgi via COPII-coated vesicles; further processing in the Golgi (extensive glycosylation, sulfation, trimming).

• Step 5: Sorting in the Golgi: decision to send cargo to the plasma membrane, lysosomes, or secretory vesicles (via TGN);

  • If destined for the lysosome, targeting signals (e.g., mannose-6-phosphate) are added.

• Step 6: Vesicles bud from the Golgi and move along cytoskeleton tracks; docking and fusion mediated by SNAREs and Rab proteins.

• Step 7: Final destination:

  • Secreted proteins released by exocytosis at the plasma membrane.

  • Membrane proteins integrated into the plasma membrane.

  • Lysosomal enzymes delivered to lysosomes.

• This pathway illustrates the coordination among nucleus (gene expression), ER (synthesis and folding), Golgi (modification and sorting), vesicles (trafficking), and plasma membrane (final destination).

Connections to prior lectures and real-world relevance

• Revisit: protein targeting signals (signal peptides, NLS, lysosomal targeting signals) and how cells read these postal codes to route proteins.

• Foundational principles: membrane continuity vs. organelle compartmentalization; energy use and transport across membranes; quality control in protein folding.

• Real-world relevance:

  • Misfolded proteins or trafficking defects can cause diseases (e.g., cystic fibrosis from mistrafficking of CFTR; lysosomal storage diseases from enzyme delivery defects).

  • Understanding organelle function informs drug design and neonatal screening for metabolic disorders.

Ethical, philosophical, and practical implications

• The study of organelles underpins medical advances; addressing organelle dysfunction can improve therapies for metabolic and genetic diseases.

• Practical considerations:

  • Targeted drug delivery and nanotechnology can exploit vesicular transport pathways.

  • Biotechnological applications leverage the secretory pathway to produce therapeutic proteins.